DrDrops
Dr.Drops 🔥 Updates on Hottest Crypto Events -> Join Community ✅ Ad
Subsquid logo

Subsquid
ICO Round on CoinList

Past 12 Jan - 18 Jan 2024 CoinList

Subsquid is a pioneering data lake and query engine network designed to help developers in collecting and analyzing information. It allows users to extract necessary information from its datasets or earn rewards for contributing data and computing power to the network.  

The $SQD public sale on CoinList has already garnered significant attention among the crypto community. During this round, Subsquid is expecting to raise over $6.2M for further developing its network.

CoinLaunch Score: Last update:
High 18 Jan 2024

Subsquid - ICO Round on CoinList  Overview

start date: 12 Jan 2024
end date: 18 Jan 2024
price: $0.094
tokens for sale: 66,850,000
Raise: $6,283,900
Min. Buy: $50
Max. Buy: $2,000
Industry: Blockchain Service
Lock-up:

20% release at TGE, followed by a 6-month linear vesting; TGE on 15 may 2024

Launchpad CoinList LogoCoinList
More about Subsquid

How to join  Subsquid - ICO Round on CoinList?

To qualify for the Subsquid ICO on CoinList, users need to verify their email, wallet, and pass a KYC verification. Then, deposit or hold a minimum amount of 50 USDC or USDT in their wallet before the registration deadline on January 15, 2024, ends. Later, they will receive an invitation link via email to purchase $SQD upfront.

Once the registration period ends, CoinList creates a randomly lined-up queue of all participants and allocates users following the order of the queue. 

For more details on how to participate in Subsquid ICO on CoinList here.

Step-by-step Guide

  • Sign up or Login into the CoinList account;

  • Own at least 50 USDT or USDC in your wallet before registration ends;

  • Apply (Register) for the Subsquid community token sale round on Coinlist;

  • Receive an invitation link to ICO;

  • Purchase the tokens upfront;

  • If didn’t registered on time, participate in FCFS round;

  • Claim your tokens.

Share this event:
No Comments
No comments yet